BioGX

May

BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance

Amsterdam, The Netherlands, 24 May 2018 – BioGX B.V. continues its *BD MAX menu expansion with the launch of six additional CE-Mark infectious disease tests on Becton, Dickinson and...

Feb

BioGX and Launch Diagnostics Announce Distribution Partnership For U.K. and Ireland

BIRMINGHAM, Ala., Feb. 8, 2018 /PRNewswire/ -- BioGX continues to expand its global presence with the announcement of a distribution partnership between BioGX's Amsterdam-based European...

Feb

BioGX BV and AxonLab AG Announce Distribution Partnership

BIRMINGHAM, Ala., Feb. 6, 2018 /PRNewswire/ -- BioGX continues to expand its international presence with the announcement of a new strategic partnership between BioGX's Amsterdam-based...

Apr

BioGX Launches Four CE-marked IVD Assays at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

VIENNA, April 24, 2017 /PRNewswire/ -- BioGX, a Birmingham Alabama based molecular diagnostics company, announced the launch of four additional CE-IVD infectious disease tests at the 27th...

What's New at BioGX

BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance

BioGX and Launch Diagnostics Announce Distribution Partnership For U.K. and Ireland

BioGX BV and AxonLab AG Announce Distribution Partnership

BioGX Launches Four CE-marked IVD Assays at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

There is currently no news to display